• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性心内膜炎的临床谱、表现及死亡危险因素:土耳其一家三级医疗中心68例病例的回顾

Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey.

作者信息

Tuğcu Aylin, Yildirimtürk Ozlem, Baytaroğlu Corç, Kurtoğlu Hilal, Köse Ozkan, Sener Murat, Aytekin Saide

机构信息

Department of Cardiology, Florence Nightingale Hospital, Istanbul Bilim University, Istanbul, Turkey.

出版信息

Turk Kardiyol Dern Ars. 2009 Jan;37(1):9-18.

PMID:19225248
Abstract

OBJECTIVES

This study was designed to evaluate clinical, laboratory, microbiological, and echocardiographic characteristics of infective endocarditis (IE) at a tertiary care center in Turkey and to identify predictors of in-hospital mortality.

STUDY DESIGN

Based on a systematic retrospective review of clinical records covering 1997 to 2007, we analyzed data and outcomes of 68 patients (40 males, 28 females; mean age 51+/-20 years) with definite or possible IE according to the modified Duke criteria.

RESULTS

Native valve endocarditis (NVE) was seen in 28 patients (41.2%), and prosthetic valve endocarditis (PVE) was seen in 38 patients (55.9%). Pacemaker endocarditis (PE) was observed in only two patients (2.9%). Nineteen patients (27.9%) had nosocomial IE. The most frequent predisposing factor for NVE was rheumatic heart disease (n=11; 39.3%). Echocardiography failed to show any signs of involvement in five patients (13.2%) with PVE. The most common causative microorganisms of NVE, PVE, and PE were staphylococci (n=28; 41.2%). At least one complication developed in 46 patients (67.7%), congestive heart failure being the most common (n=38; 55.9%). Forty-one patients (60.3%) underwent combined medical and surgical treatment. In-hospital mortality occurred in 17 patients (25%). Mortality rates were 37.5%, 30%, and 14.3% for early and late PVE and NVE, respectively. Mortality was significantly higher with nosocomial IE (57.9%) compared to 12.2% in the remaining patients. In multivariate analysis, septic shock (p=0.011) and nosocomial infection (p=0.032) were independently associated with in-hospital mortality.

CONCLUSION

Compared to the European series, IE in our cohort occurred in a relatively younger population, with rheumatic heart disease as the most common underlying heart disease. The rates of PVE, nosocomial IE, and surgical treatment were about the same.

摘要

目的

本研究旨在评估土耳其一家三级医疗中心感染性心内膜炎(IE)的临床、实验室、微生物学及超声心动图特征,并确定院内死亡的预测因素。

研究设计

基于对1997年至2007年临床记录的系统回顾,我们根据改良的杜克标准分析了68例确诊或可能患有IE患者(40例男性,28例女性;平均年龄51±20岁)的数据及结果。

结果

28例患者(41.2%)为自体瓣膜心内膜炎(NVE),38例患者(55.9%)为人工瓣膜心内膜炎(PVE)。仅2例患者(2.9%)为起搏器心内膜炎(PE)。19例患者(27.9%)患有医院获得性IE。NVE最常见的易感因素是风湿性心脏病(n = 11;39.3%)。超声心动图未显示5例(13.2%)PVE患者有任何受累迹象。NVE、PVE和PE最常见的致病微生物是葡萄球菌(n = 28;41.2%)。46例患者(67.7%)至少发生一种并发症,充血性心力衰竭最为常见(n = 38;55.9%)。41例患者(60.3%)接受了药物和手术联合治疗。17例患者(25%)发生院内死亡。早期和晚期PVE及NVE的死亡率分别为37.5%、30%和14.3%。医院获得性IE的死亡率(57.9%)显著高于其余患者的12.2%。多因素分析显示,感染性休克(p = 0.011)和医院获得性感染(p = 0.032)与院内死亡独立相关。

结论

与欧洲系列研究相比,我们队列中的IE发生在相对年轻的人群中,风湿性心脏病是最常见的潜在心脏病。PVE、医院获得性IE和手术治疗的发生率大致相同。

相似文献

1
Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey.感染性心内膜炎的临床谱、表现及死亡危险因素:土耳其一家三级医疗中心68例病例的回顾
Turk Kardiyol Dern Ars. 2009 Jan;37(1):9-18.
2
Early outcome after surgery for active native and prosthetic aortic valve endocarditis.活动性天然主动脉瓣和人工主动脉瓣心内膜炎手术后的早期结果。
J Heart Valve Dis. 2008 Sep;17(5):508-24; discussion 525.
3
Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region.东南安纳托利亚地区一家三级医院感染性心内膜炎的流行病学、临床和微生物学特征
Turk Kardiyol Dern Ars. 2010 Mar;38(2):107-11.
4
Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis.比较人工瓣膜心内膜炎和原发性瓣膜心内膜炎中真菌性感染性心内膜炎的特征和短期预后。
Am J Cardiol. 2013 Jul 1;112(1):111-6. doi: 10.1016/j.amjcard.2013.02.068. Epub 2013 Apr 3.
5
[Treatment outcome of prosthetic valve endocarditis].[人工瓣膜心内膜炎的治疗结果]
Przegl Lek. 2003;60(9):549-52.
6
Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.感染性二尖瓣心内膜炎的外科治疗:早期和晚期预后的预测因素
J Heart Valve Dis. 2000 May;9(3):327-34.
7
Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data.希腊的感染性心内膜炎:不断变化的特征。流行病学、微生物学及治疗数据。
Clin Microbiol Infect. 2004 Jun;10(6):556-61. doi: 10.1111/j.1469-0691.2004.00884.x.
8
Aortic valve endocarditis. Determinants of early survival and late morbidity.主动脉瓣心内膜炎。早期生存及晚期发病的决定因素。
Circulation. 1994 Nov;90(5 Pt 2):II175-82.
9
Long-term results and determinants of mortality after surgery for native and prosthetic valve endocarditis.自体瓣膜和人工瓣膜心内膜炎手术后的长期结果及死亡决定因素。
J Heart Valve Dis. 2001 Nov;10(6):694-702.
10
Short- and long-term outcomes of surgery for active infective endocarditis: a Tunisian experience.活动性感染性心内膜炎手术的短期和长期结果:突尼斯的经验
Interact Cardiovasc Thorac Surg. 2009 Aug;9(2):241-5. doi: 10.1510/icvts.2008.197715. Epub 2009 May 4.

引用本文的文献

1
Infective Endocarditis by Species-A Narrative Review.按菌种分类的感染性心内膜炎——一篇综述
Pathogens. 2024 Jul 17;13(7):594. doi: 10.3390/pathogens13070594.
2
A Three-Year Retrospective Study Assessing the Quality of the Course of Management of Infective Endocarditis in a Tertiary Hospital in Riyadh, Saudi Arabia.一项为期三年的回顾性研究:评估沙特阿拉伯利雅得一家三级医院感染性心内膜炎的治疗过程质量
Cureus. 2023 Apr 13;15(4):e37539. doi: 10.7759/cureus.37539. eCollection 2023 Apr.
3
An epidemiological study to define the recent clinical characteristics and outcomes of infective endocarditis in southern Turkey.
一项在土耳其南部进行的流行病学研究,旨在明确近期感染性心内膜炎的临床特征和结局。
Cardiovasc J Afr. 2021;32(4):188-192. doi: 10.5830/CVJA-2021-009. Epub 2021 Apr 7.
4
Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group.土耳其心血管外科学会(TSCVS)、土耳其临床微生物学和传染病学会(KLIMIK)、土耳其心脏病学会(TSC)、土耳其核医学学会(TSNM)、土耳其放射学会(TSR)、土耳其牙科协会(TDA)以及土耳其病理学会联合会(TURKPATH)心血管系统研究组关于感染性心内膜炎诊断、治疗及预防的共识报告
Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Jan 23;28(1):2-42. doi: 10.5606/tgkdc.dergisi.2020.01954. eCollection 2020 Jan.
5
D-Dimer is a strong predictor of in-hospital mortality in patients with infective endocarditis.D-二聚体是感染性心内膜炎患者院内死亡率的有力预测指标。
Anatol J Cardiol. 2019 Mar;21(3):124-133. doi: 10.14744/AnatolJCardiol.2018.56752.
6
Endocarditis in the Mediterranean Basin.地中海地区的心内膜炎
New Microbes New Infect. 2018 May 30;26:S43-S51. doi: 10.1016/j.nmni.2018.05.004. eCollection 2018 Nov.
7
Clinicomicrobiological spectrum of infective endocarditis - from a tertiary care centre in south India.印度南部一家三级医疗中心感染性心内膜炎的临床微生物谱
Iran J Microbiol. 2017 Oct;9(5):257-263.
8
The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.感染性心内膜炎的病原体:一项纳入33214例病例的系统评价
Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1227-45. doi: 10.1007/s10096-016-2660-6. Epub 2016 May 11.
9
Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis.感染性心内膜炎患者青霉素G的群体药代动力学分析及给药方案优化
J Pharm Health Care Sci. 2016 Apr 5;2:9. doi: 10.1186/s40780-016-0043-x. eCollection 2016.
10
Infective endocarditis: a tertiary referral centre experience from Turkey.感染性心内膜炎:来自土耳其一家三级转诊中心的经验
Int J Clin Exp Med. 2015 Aug 15;8(8):13962-8. eCollection 2015.